000 01771 a2200445 4500
005 20250512023717.0
264 0 _c19871223
008 198712s 0 0 eng d
022 _a0027-8424
024 7 _a10.1073/pnas.84.22.8160
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aReinhard, J F
245 0 0 _aSubcellular compartmentalization of 1-methyl-4-phenylpyridinium with catecholamines in adrenal medullary chromaffin vesicles may explain the lack of toxicity to adrenal chromaffin cells.
_h[electronic resource]
260 _bProceedings of the National Academy of Sciences of the United States of America
_cNov 1987
300 _a8160-4 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _a1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine
650 0 4 _a1-Methyl-4-phenylpyridinium
650 0 4 _aAdrenal Medulla
_xmetabolism
650 0 4 _aAnimals
650 0 4 _aCalcium
_xpharmacology
650 0 4 _aCatecholamines
_xanalysis
650 0 4 _aCattle
650 0 4 _aCell Compartmentation
650 0 4 _aCells, Cultured
650 0 4 _aDesipramine
_xpharmacology
650 0 4 _aDigitonin
_xpharmacology
650 0 4 _aDrug Interactions
650 0 4 _aNicotine
_xpharmacology
650 0 4 _aPyridines
_xpharmacokinetics
650 0 4 _aPyridinium Compounds
_xmetabolism
650 0 4 _aSubcellular Fractions
_xanalysis
650 0 4 _aTetrabenazine
_xpharmacology
650 0 4 _aTyrosine 3-Monooxygenase
_xantagonists & inhibitors
700 1 _aDiliberto, E J
700 1 _aViveros, O H
700 1 _aDaniels, A J
773 0 _tProceedings of the National Academy of Sciences of the United States of America
_gvol. 84
_gno. 22
_gp. 8160-4
856 4 0 _uhttps://doi.org/10.1073/pnas.84.22.8160
_zAvailable from publisher's website
999 _c2896983
_d2896983